Pharmaceutical Sciences


Process Development of Drugs Repurposed for COVID-19


Life Sciences & Biotechnology, Pharmaceutical Sciences, COVID-19 Technology

Focus Area:

Development of Repurposed Drugs for COVID-19

Developing Agency:

National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram

Technology Readiness Index:

Technology development
Website Link :

Brief Description

Description :

Process developed for Nitazoxanide, EIDD 1931 & EIDD 2801. Non-infringing routes developed for the APIs. Nitazoxanide is currently under clinical trials in Mexico. EIDD 2801 is currently under clinical trials in USA & UK.

Related Technologies